Previous studies on animal models showed that silencing of BSP in human breast cancer and human lung cancer cells inhibits the development of bone metastases (20,76,77), possibly owing to decreased expression levels of αvβ3 (77) and MMP-14 (20). This evidence concerns the gene MMP14 and breast carcinoma.